Superior Planning LLC’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$62 Buy
+3
New +$70 ﹤0.01% 2107

Other funds holding DNLI

Superior Planning LLC's DNLI Position: Q3 2026 in Review

Superior Planning LLC opened a new position in Denali Therapeutics (DNLI) in Q3 2026: 3 shares worth $62. The stake represents ﹤0.01% of the portfolio and ranks #2107 among its holdings.

221 funds tracked by Wall St. Rank hold DNLI as of Q3 2026.

  • Superior Planning LLC held 3 shares of Denali Therapeutics worth $62 as of Q3 2026.
  • Denali Therapeutics was a new Superior Planning LLC position in Q3 2026.
  • Denali Therapeutics made up ﹤0.01% of Superior Planning LLC's portfolio in Q3 2026, its #2107 holding.
  • 221 funds tracked by Wall St. Rank held Denali Therapeutics as of Q3 2026.

Based on Superior Planning LLC's 13F filing for Q3 2026, filed 12 Nov 2026.